{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:39:31Z","timestamp":1782959971475,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00428-024-03993-4","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:39:54Z","timestamp":1733272794000},"page":"61-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High expression of RHOF is an effective diagnostic marker and a potential prognostic indicator for primary mediastinal large B-cell lymphoma"],"prefix":"10.1007","volume":"487","author":[{"given":"Xinyi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5663-6006","authenticated-orcid":false,"given":"Xiaoli","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"issue":"9","key":"3993_CR1","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1182\/blood.2020008376","volume":"140","author":"KJ Savage","year":"2022","unstructured":"Savage KJ (2022) Primary mediastinal large B-cell lymphoma. Blood 140(9):955\u2013970. https:\/\/doi.org\/10.1182\/blood.2020008376","journal-title":"Blood"},{"issue":"4","key":"3993_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/ajcp\/aqab122","volume":"156","author":"SL Ondrejka","year":"2021","unstructured":"Ondrejka SL, Ott G (2021) How I diagnose primary mediastinal (thymic) large B-cell lymphoma. Am J Clin Pathol 156(4):497\u2013512. https:\/\/doi.org\/10.1093\/ajcp\/aqab122","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"3993_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36(7):1720\u20131748","journal-title":"Leukemia"},{"issue":"7","key":"3993_CR4","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00277-023-05225-2","volume":"102","author":"H Zhou","year":"2023","unstructured":"Zhou H, Liu Q, Lu S, Zou L (2023) Primary mediastinal\/thymic diffuse large B-cell lymphoma: a population-based study on incidence and survival. Ann Hematol 102(7):1879\u20131886. https:\/\/doi.org\/10.1007\/s00277-023-05225-2","journal-title":"Ann Hematol"},{"key":"3993_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ceb.2015.08.005","volume":"36","author":"AJ Ridley","year":"2015","unstructured":"Ridley AJ (2015) Rho GTPase signalling in cell migration. Curr Opin Cell Biol 36:103\u2013112. https:\/\/doi.org\/10.1016\/j.ceb.2015.08.005","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"3993_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3892\/ijo.2017.4093","volume":"51","author":"GA Cardama","year":"2017","unstructured":"Cardama GA, Gonzalez N, Maggio J, Menna PL, Gomez DE (2017) Rho GTPases as therapeutic targets in cancer (review). Int J Oncol 51(4):1025\u20131034. https:\/\/doi.org\/10.3892\/ijo.2017.4093","journal-title":"Int J Oncol"},{"issue":"4","key":"3993_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/21541248.2016.1232583","volume":"7","author":"RB Haga","year":"2016","unstructured":"Haga RB, Ridley AJ (2016) Rho GTPases: regulation and roles in cancer cell biology. Small GTPases 7(4):207\u2013221. https:\/\/doi.org\/10.1080\/21541248.2016.1232583","journal-title":"Small GTPases"},{"issue":"18","key":"3993_CR8","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.7150\/jca.52648","volume":"12","author":"Y Hou","year":"2021","unstructured":"Hou Y, Zi J, Ge Z (2021) High expression of rhof predicts worse overall survival: a potential therapeutic target for non-M3 acute myeloid leukemia. J Cancer 12(18):5530\u20135542. https:\/\/doi.org\/10.7150\/jca.52648","journal-title":"J Cancer"},{"issue":"2","key":"3993_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.bbrc.2019.04.018","volume":"513","author":"R Sugawara","year":"2019","unstructured":"Sugawara R, Ueda H, Honda R (2019) Structural and functional characterization of fast-cycling RhoF GTPase. Biochem Biophys Res Commun 513(2):522\u2013527. https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.018","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"3993_CR10","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1182\/blood-2009-04-214676","volume":"114","author":"F Guo","year":"2009","unstructured":"Guo F, Velu CS, Grimes HL, Zheng Y (2009) Rho GTPase Cdc42 is essential for B-lymphocyte development and activation. Blood 114(14):2909\u20132916. https:\/\/doi.org\/10.1182\/blood-2009-04-214676","journal-title":"Blood"},{"issue":"5644","key":"3993_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1126\/science.1089709","volume":"302","author":"MJ Walmsley","year":"2003","unstructured":"Walmsley MJ, Ooi SK, Reynolds LF, Smith SH, Ruf S, Mathiot A, Vanes L, Williams DA, Cancro MP, Tybulewicz VL (2003) Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 302(5644):459\u2013462. https:\/\/doi.org\/10.1126\/science.1089709","journal-title":"Science"},{"issue":"3","key":"3993_CR12","doi-asserted-by":"publisher","first-page":"e33773","DOI":"10.1371\/journal.pone.0033773","volume":"7","author":"S Zhang","year":"2012","unstructured":"Zhang S, Zhou X, Lang RA, Guo F (2012) RhoA of the Rho family small GTPases is essential for B lymphocyte development. PLoS ONE 7(3):e33773. https:\/\/doi.org\/10.1371\/journal.pone.0033773","journal-title":"PLoS ONE"},{"issue":"3\u20134","key":"3993_CR13","first-page":"293","volume":"76","author":"M Kishimoto","year":"2014","unstructured":"Kishimoto M, Matsuda T, Yanase S, Katsumi A, Suzuki N, Ikejiri M, Takagi A, Ikawa M, Kojima T, Kunishima S, Kiyoi H, Naoe T, Matsushita T, Maruyama M (2014) Rhof promotes murine marginal zone B cell development. Nagoya J Med Sci 76(3\u20134):293\u2013305","journal-title":"Nagoya J Med Sci"},{"issue":"4","key":"3993_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1365-2141.2005.05481.x","volume":"129","author":"LG Gouw","year":"2005","unstructured":"Gouw LG, Reading NS, Jenson SD, Lim MS, Elenitoba-Johnson KS (2005) Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas. Br J Haematol 129(4):531\u2013533. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05481.x","journal-title":"Br J Haematol"},{"key":"3993_CR15","unstructured":"WHO Classification of Tumours Editorial Board (2024) Haematolymphoid tumours.\u00a0WHO classification of tumours series, vol 11, 5th edn. Lyon (France): International Agency for Research on Cancer. Available from: https:\/\/tumourclassification.iarc.who.int"},{"key":"3993_CR16","doi-asserted-by":"publisher","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood, 140(11):1229-1253. https:\/\/doi.org\/10.1182\/blood.2022015851. Erratum in: Blood. 2023;141(4):437. https:\/\/doi.org\/10.1182\/blood.2022019016","DOI":"10.1182\/blood.2022015851"},{"issue":"2","key":"3993_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1182\/blood.2020007683","volume":"138","author":"G Duns","year":"2021","unstructured":"Duns G, Vigan\u00f2 E, Ennishi D, Sarkozy C, Hung SS, Chavez E et al (2021) Characterization of DLBCL with a PMBL gene expression signature. Blood 138(2):136\u2013148. https:\/\/doi.org\/10.1182\/blood.2020007683","journal-title":"Blood"},{"issue":"3","key":"3993_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3760\/cma.j.cn121090-20231107-00252","volume":"45","author":"Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association; Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO)","year":"2024","unstructured":"Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association; Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO) (2024) Chinese expert consensus on the diagnosis and management of primary mediastinal large B-cell lymphoma. Zhonghua Xue Ye Xue Za Zhi 45(3):209\u2013214. https:\/\/doi.org\/10.3760\/cma.j.cn121090-20231107-00252","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"12","key":"3993_CR19","doi-asserted-by":"publisher","first-page":"204062072110489","DOI":"10.1177\/20406207211048959","volume":"8","author":"B Fakhri","year":"2021","unstructured":"Fakhri B, Ai W (2021) Current and emerging treatment options in primary mediastinal B-cell lymphoma. Ther Adv Hematol 8(12):20406207211048960. https:\/\/doi.org\/10.1177\/20406207211048959","journal-title":"Ther Adv Hematol"},{"issue":"15","key":"3993_CR20","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","volume":"368","author":"K Dunleavy","year":"2013","unstructured":"Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J et al (2013) Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med 368(15):1408\u20131416. https:\/\/doi.org\/10.1056\/NEJMoa1214561","journal-title":"N Engl J Med"},{"issue":"3","key":"3993_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3324\/haematol.2023.283446","volume":"109","author":"MR Cook","year":"2024","unstructured":"Cook MR, Williams LS, Dorris CS, Luo Y, Makambi K, Dunleavy K (2024) Improved survival for dose-intensive chemotherapy in primary mediastinal B-cell lymphoma: a systematic review and meta-analysis of 4,068 patients. Haematologica 109(3):846\u2013856. https:\/\/doi.org\/10.3324\/haematol.2023.283446","journal-title":"Haematologica"},{"issue":"4","key":"3993_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/bjh.15051","volume":"180","author":"NN Shah","year":"2018","unstructured":"Shah NN, Szabo A, Huntington SF, Epperla N, Reddy N, Ganguly S et al (2018) R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis. Br J Haematol 180(4):534\u2013544. https:\/\/doi.org\/10.1111\/bjh.15051","journal-title":"Br J Haematol"},{"issue":"33","key":"3993_CR23","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1200\/JCO.19.01492","volume":"37","author":"PL Zinzani","year":"2019","unstructured":"Zinzani PL, Santoro A, Gritti G, Brice P, Barr PM, Kuruvilla J et al (2019) Nivolumab combined with brentuximab vedotin for relapsed\/refractory primary mediastinal large B-cell lymphoma: efficacy and safety from the phase II CheckMate 436 Study. J Clin Oncol 37(33):3081\u20133089. https:\/\/doi.org\/10.1200\/JCO.19.01492","journal-title":"J Clin Oncol"},{"issue":"11","key":"3993_CR24","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1016\/j.clml.2021.06.012","volume":"21","author":"Z Ahmed","year":"2021","unstructured":"Ahmed Z, Afridi SS, Shahid Z, Zamani Z, Rehman S, Aiman W et al (2021) Primary mediastinal B-cell lymphoma: a 2021 update on genetics, diagnosis, and novel therapeutics. Clin Lymphoma Myeloma Leuk 21(11):e865\u2013e875. https:\/\/doi.org\/10.1016\/j.clml.2021.06.012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7338","key":"3993_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nature09754","volume":"471","author":"C Steidl","year":"2011","unstructured":"Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P et al (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471(7338):377\u2013381. https:\/\/doi.org\/10.1038\/nature09754","journal-title":"Nature"},{"issue":"22","key":"3993_CR26","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1182\/blood-2018-05-851154","volume":"132","author":"A Mottok","year":"2018","unstructured":"Mottok A, Wright G, Rosenwald A, Ott G, Ramsower C, Campo E et al (2018) Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens. Blood 132(22):2401\u20132405. https:\/\/doi.org\/10.1182\/blood-2018-05-851154","journal-title":"Blood"},{"issue":"6","key":"3993_CR27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jmoldx.2017.07.007","volume":"19","author":"V Bob\u00e9e","year":"2017","unstructured":"Bob\u00e9e V, Ruminy P, Marchand V, Viailly PJ, Abdel Sater A, Veresezan L et al (2017) Determination of molecular subtypes of diffuse large b-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM study. J Mol Diagn 19(6):892\u2013904. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.07.007","journal-title":"J Mol Diagn"},{"issue":"13","key":"3993_CR28","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","volume":"123","author":"DD Twa","year":"2014","unstructured":"Twa DD, Chan FC, Ben-Neriah S, Woolcock BW, Mottok A, Tan KL et al (2014) Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma. Blood 123(13):2062\u20132065. https:\/\/doi.org\/10.1182\/blood-2013-10-535443","journal-title":"Blood"},{"issue":"26","key":"3993_CR29","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1182\/blood.2019002067","volume":"134","author":"B Chapuy","year":"2019","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Wienand K, Kamburov A et al (2019) Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade. Blood 134(26):2369\u20132382. https:\/\/doi.org\/10.1182\/blood.2019002067","journal-title":"Blood"},{"issue":"23","key":"3993_CR30","doi-asserted-by":"publisher","first-page":"7331","DOI":"10.1182\/bloodadvances.2023011169","volume":"7","author":"V Camus","year":"2023","unstructured":"Camus V, Viailly PJ, Drieux F, Veresezan EL, Sesques P, Haioun C et al (2023) High PDL1\/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma. Blood Adv 7(23):7331\u20137345. https:\/\/doi.org\/10.1182\/bloodadvances.2023011169","journal-title":"Blood Adv"},{"issue":"2","key":"3993_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/PAS.0000000000000771","volume":"41","author":"M Gentry","year":"2017","unstructured":"Gentry M, Bodo J, Durkin L, Hsi ED (2017) Performance of a commercially available MAL antibody in the diagnosis of primary mediastinal large B-cell lymphoma. Am J Surg Pathol 41(2):189\u2013194. https:\/\/doi.org\/10.1097\/PAS.0000000000000771","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"3993_CR32","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/modpathol.2012.129","volume":"25","author":"DM Dorfman","year":"2012","unstructured":"Dorfman DM, Shahsafaei A, Alonso MA (2012) Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers. Mod Pathol 25(12):1637\u20131643. https:\/\/doi.org\/10.1038\/modpathol.2012.129","journal-title":"Mod Pathol"},{"issue":"1","key":"3993_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/01.pas.0000213334.40358.0e","volume":"31","author":"SJ Rodig","year":"2007","unstructured":"Rodig SJ, Savage KJ, LaCasce AS, Weng AP, Harris NL, Shipp MA et al (2007) Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma. Am J Surg Pathol 31(1):106\u2013112. https:\/\/doi.org\/10.1097\/01.pas.0000213334.40358.0e","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"3993_CR34","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1097\/PAS.0b013e31822bd476","volume":"35","author":"S Kondratiev","year":"2011","unstructured":"Kondratiev S, Duraisamy S, Unitt CL, Green MR, Pinkus GS, Shipp MA et al (2011) Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas. Am J Surg Pathol 35(10):1531\u20131539. https:\/\/doi.org\/10.1097\/PAS.0b013e31822bd476","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"3993_CR35","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1097\/PAS.0000000000000473","volume":"39","author":"J Yuan","year":"2015","unstructured":"Yuan J, Wright G, Rosenwald A, Steidl C, Gascoyne RD, Connors JM et al (2015) Identification of primary mediastinal large B-cell lymphoma at nonmediastinal sites by gene expression profiling. Am J Surg Pathol 39(10):1322\u20131330. https:\/\/doi.org\/10.1097\/PAS.0000000000000473","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3993_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","volume":"108","author":"RA Roberts","year":"2006","unstructured":"Roberts RA, Wright G, Rosenwald AR, Jaramillo MA, Grogan TM, Miller TP et al (2006) Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival. Blood 108(1):311\u2013318. https:\/\/doi.org\/10.1182\/blood-2005-11-4742","journal-title":"Blood"},{"issue":"1","key":"3993_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/ijms25010142","volume":"25","author":"Y Su","year":"2023","unstructured":"Su Y, Wang F, Lei Z, Li J, Ma M, Yan Y et al (2023) An integrated multi-omics analysis identifying immune subtypes of pancreatic cancer. Int J Mol Sci 25(1):142. https:\/\/doi.org\/10.3390\/ijms25010142","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3993_CR38","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/hep.31641","volume":"73","author":"S Li","year":"2021","unstructured":"Li S, Liu Y, Bai Y, Chen M, Cheng D, Wu M et al (2021) Ras homolog family member F, Filopodia associated promotes hepatocellular carcinoma metastasis by altering the metabolic status of cancer cells through RAB3D. Hepatology 73(6):2361\u20132379. https:\/\/doi.org\/10.1002\/hep.31641","journal-title":"Hepatology"},{"issue":"12","key":"3993_CR39","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/gcc.20601","volume":"47","author":"A Carbone","year":"2008","unstructured":"Carbone A, Bernardini L, Valenzano F, Bottillo I, De Simone C, Capizzi R et al (2008) Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC\/DIABLO, and RHOF. Genes Chromosomes Cancer 47(12):1067\u20131075. https:\/\/doi.org\/10.1002\/gcc.20601","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03993-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03993-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03993-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T01:26:32Z","timestamp":1757121992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03993-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3993"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03993-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study obtained approval from the Ethics Committee of Cancer Hospital of the Chinese Academy of Medical Sciences & Peking Union Medical College (Approval No: 2024070409114002). Individual consent for this retrospective analysis was waived, and all data were analyzed anonymously.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}